Corbus Pharmaceuticals Holdings, Inc. Balance Sheet
CRBP|8 years of annual SEC 10-K data (FY2015-FY2022)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Corbus Pharmaceuticals Holdings, Inc. had $66M in total assets and $69M in shareholders' equity as of FY2022. Total debt was $16M against $17M in cash, resulting in a $1M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17.0M | $25.0M | $85.4M | $31.7M | $41.7M | $62.5M | $15.0M | $6.3M |
| Current Assets | $60.2M | $100.2M | $92.1M | $38.2M | $44.2M | $65.5M | $17.4M | $12.7M |
| PP&E (Net) | $1.6M | $2.4M | $4.1M | $5.1M | $2.7M | $1.4M | $435.3K | $124.1K |
| Total Assets | $66.3M | $107.7M | $102.3M | $49.1M | $47.0M | $67.0M | $17.9M | $12.9M |
| Current Liabilities | $12.6M | $17.0M | $31.9M | $34.9M | $18.1M | $8.2M | $8.9M | $3.6M |
| Total Debt | $16.0M | $15.6M | $18.0M | - | - | - | - | - |
| Shareholders' Equity | $69.1M | $45.3M | $6.2M | $27.5M | $57.8M | $8.9M | $5.9M | $5.9M |